Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents: the Dual Antiplatelet Therapy Randomized Clinical Trial

IMPORTANCE: Despite antirestenotic efficacy of coronary drug-eluting stents (DES) compared with bare metal stents (BMS), the relative risk of stent thrombosis and adverse cardiovascular events is unclear. Although dual antiplatelet therapy (DAPT) beyond one year provides ischemic event protection fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Kereiakes, Dean J., Yeh, Robert W., Massaro, Joseph M., Driscoll-Shempp, Priscilla, Cutlip, Donald E., Steg, P. Gabriel, Gershlick, Anthony H., Darius, Harald, Meredith, Ian T., Ormiston, John, Tanguay, Jean Francois, Windecker, Stephan, Garratt, Kirk N., Kandzari, David E., Lee, David P., Simon, Daniel I., Iancu, Adrian Corneliu, Trebacz, Jaroslaw, Mauri, Laura
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481320/
https://ncbi.nlm.nih.gov/pubmed/25781440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2015.1671
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados